Health Condition 1: 3- Administration
Conditions
Interventions
Intervention1: Perineural dextrose prolotherapy: patients with occipital neuralgia will be given perineural injection of 1 ml 5% dextrose and 1 ml 2% lignocaine around Greater, lesser and/or third occ
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: Diagnose case of occipital neuralgia according to ICHD 3 criteria A Unilateral or bilateral pain fulfilling criteria B to E B Pain is located in the distribution of the greater, lesser, and/or third occipital nerves C Pain has two of the following three characteristics 1 Recurring in paroxysmal attacks lasting from a few seconds to minutes 2 Severe intensity 3 Shooting, stabbing, or sharp in quality D Pain is associated with both of the following 1 Dysaesthesia and/or allodynia apparent during innocuous stimulation of the scalp and/or hair 2 Either or both of the following a Tenderness over the affected nerve branches b Trigger points at the emergence of the greater occipital nerve or in the area of distribution of C2 E Pain is eased temporarily by local anesthetic block of the affected nerve F Not better accounted for by another ICHD 3 diagnosis
Exclusion criteria
Exclusion criteria: 1 Pregnant females 2 Patients below the age of 18 and above 75 3 Patient with uncontrolled diabetes mellitus 4 Patient on analgesic medication for condition other than occipital neuralgia 5 Patients with neuralgia due to tumor, acute infection and/or trauma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain reduction via VAS score and Barrow Neurological Pain ScaleTimepoint: 1) pre procedure 2) 2 weeks post procedure 3) 4 weeks post procedure 4) 8 weeks post procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in quality of life as measure by SF-12 scaleTimepoint: 1) pre procedure 2) 2 weeks post procedure 3) 4 weeks post procedure 4) 8 weeks post procedure;ii) To study the efficacy of perineural dextrose prolotherapy and perineural steroid injection in the treatment of patient with occipital neuralgiaTimepoint: 1) pre procedure 2) 2 weeks post procedure 3) 4 weeks post procedure 4) 8 weeks post procedure;To study the dermatomal distribution of occipital neuralgia in Greater Occipital Nerve, Lesser occipital Nerve and third occipital NerveTimepoint: ;Document characteristic of background pain (quality, location, and intensity) and pain exacerbations (frequency, duration, quality) in occipital neuralgiaTimepoint: | — |
Countries
India
Contacts
Public ContactDr Sonali Sahani
AIIMS, Nagpur
Outcome results
None listed